Dietary intake of medium- and long-chain triacylglycerols ameliorates insulin resistance in rats fed a high-fat diet

Nutrition

Volumn 28, Issue 1, 2012, Pages 92-97

  Terada, Shin ^a   Yamamoto, Sayuri ^a   Sekine, Seiji ^a   Aoyama, Toshiaki ^a  

^a The Nisshin OilliO Group   (Japan)

Author keywords

Adiponectin; High fat diet; Insulin resistance; Medium chain fatty acids; Rat

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE; INSULIN; LIPID; LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN TRIACYLGLYCEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; RESISTIN;

ABDOMINAL FAT; ANIMAL CELL; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIETARY INTAKE; EPIDIDYMIS FAT; FOOD INTAKE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LIPID DIET; LIVER WEIGHT; MALE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RAT;

ADIPONECTIN; ADIPOSITY; ANIMALS; BODY WEIGHT; DIET, HIGH-FAT; DIETARY FATS; FATTY ACIDS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; OVERWEIGHT; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES;

RATTUS;

EID: 83355163283     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2011.04.008     Document Type: Article

References (43)

1. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
2. Martin B.C., Warram J.H., Krolewski A.S., Bergman R.N., Soeldner J.S., Kahn C.R. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 1992, 340:925-929.
3. Kissebah A.H. Insulin resistance in visceral obesity. Int J Obes 1991, 15:109-115.
4. Matsuzawa Y. The role of fat topology in the risk of disease. Int J Obes 2008, 32:S83-S92.
5. Bach A.C., Babayan V.K. Medium-chain triglycerides: an update. Am J Clin Nutr 1982, 36:950-962.
6. Chow B.P., Shaffer E.A., Parsons H.G. Absorption of triglycerides in the absence of lipase. Can J Physiol Pharmacol 1990, 68:519-523.
7. Greenberger N.J., Skillman T.G. Medium-chain triglycerides. N Engl J Med 1969, 280:1045-1058.
8. Zurier R.B., Campbell R.G., Hashim S.A., Van Itallie T.B. Enrichment of depot fat with odd and even numbered medium chain fatty acids. Am J Physiol 1967, 212:291-294.
9. Lavau M.M., Hashim S.A. Effect of medium chain triglyceride on lipogenesis and body fat in the rat. J Nutr 1978, 108:613-620.
10. Bray G.A., Lee M., Bray T.L. Weight gain of rats fed medium-chain triglycerides is less than rats fed long-chain triglycerides. Int J Obes 1980, 4:27-32.
11. Crozier G., Bois-Joyeux B., Chanez M., Girard J., Peret J. Metabolic effects induced by long-term feeding of medium-chain triglycerides in the rat. Metabolism 1987, 36:807-814.
12. Tsuji H., Kasai M., Takeuchi H., Nakamura M., Okazaki M., Kondo K. Dietary medium-chain triacylglycerols suppress accumulation of body fat in a double-blind, controlled trial in healthy men and women. J Nutr 2001, 131:2853-2859.
13. Han J., Hamilton J.A., Kirkland J.L., Corkey B.E., Guo W. Medium-chain oil reduces fat mass and down-regulates expression of adipogenic genes in rats. Obes Res 2003, 11:734-744.
14. Han J.R., Deng B., Sun J., Chen C.G., Corkey B.E., Kirkland J.L., et al. Effects of dietary medium-chain triglyceride on weight loss and insulin sensitivity in a group of moderately overweight free-living type 2 diabetic Chinese subjects. Metabolism 2007, 56:985-991.
15. Eckel R.H., Hanson A.S., Chen A.Y., Berman J.N., Yost T.J., Brass E.P. Dietary substitution of medium-chain triglycerides improves insulin-mediated glucose metabolism in NIDDM subjects. Diabetes 1992, 41:641-647.
16. Turner N., Hariharan K., TidAng J., Frangioudakis G., Beale S.M., Wright L.E., et al. Enhancement of muscle mitochondrial oxidative capacity and alterations in insulin action are lipid species dependent: potent tissue-specific effects of medium-chain fatty acids. Diabetes 2009, 58:2547-2554.
17. Takeuchi H., Noguchi O., Sekine S., Kobayashi A., Aoyama T. Lower weight gain and higher expression and blood levels of adiponectin in rats fed medium-chain TAG compared with long-chain TAG. Lipids 2006, 41:207-212.
18. Negishi N., Shirasawa S., Arai Y., Suzuki J., Mukataka S. Activation of powdered lipase by cluster water and the use of lipase powders for commercial esterification of food oils. Enzyme Microb Technol 2003, 32:66-70.
19. Aoyama T., Nosaka N., Kasai M. Research on the nutritional characteristics of medium-chain fatty acids. J Med Invest 2007, 54:385-388.
20. Ogawa A., Nosaka N., Kasai M., Aoyama T., Okazaki M., Igarashi O., Kondo K. Dietary medium- and long-chain triacylglycerols accelerate diet-induced thermogenesis in humans. J Oleo Sci 2007, 56:283-287.
21. Shinohara H., Ogawa A., Kasai M., Aoyama T. Effect of randomly interesterified triacylglycerols containing medium- and long-chain fatty acids on energy expenditure and hepatic fatty acid metabolism in rats. Biosci Biotechnol Biochem 2005, 69:1811-1818.
22. Matsuo T., Matsuo M., Kasai M., Takeuchi H. Effects of a liquid diet supplement containing structured medium- and long-chain triacylglycerols on body fat accumulation in healthy young subjects. Asia Pac J Clin Nutr 2001, 10:46-50.
23. Noguchi O., Shimada H., Kubota F., Tsuji H., Aoyama T. Nutritional effects of randomly interesterified and physically mixed oil containing medium-chain fatty acids on rats. J Oleo Sci 2002, 51:699-703.
24. Shinohara H., Wu J., Kasai M., Aoyama T. Randomly interesterified triacylglycerol containing medium- and long-chain fatty acids stimulates fatty acid metabolism in white adipose tissue of rats. Biosci Biotechnol Biochem 2006, 70:2919-2926.
25. Takeuchi H., Kubota F., Itakura M., Taguchi N. Effect of triacylglycerols containing medium- and long-chain fatty acids on body fat accumulation in rats. J Nutr Sci Vitaminol 2001, 47:267-269.
26. Kasai M., Nosaka N., Maki H., Negishi S., Aoyama T., Nakamura M., et al. Effect of dietary medium- and long-chain triacylglycerols (MLCT) on accumulation of body fat in healthy humans. Asia Pac J Clin Nutr 2003, 12:151-160.
27. Han D.H., Hansen P.A., Host H.H., Holloszy J.O. Insulin resistance of muscle glucose transport in rats fed a high-fat diet: a reevaluation. Diabetes 1997, 46:1761-1767.
28. Hancock C.R., Han D.H., Chen M., Terada S., Yasuda T., Wright D.C., Holloszy J.O. High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc Natl Acad Sci U S A 2008, 105:7815-7820.
29. Kim J.Y., Nolte L.A., Hansen P.A., Han D.H., Ferguson K., Thompson P.A., Holloszy J.O. High-fat diet-induced muscle insulin resistance: relationship to visceral fat mass. Am J Physiol Regul Integr Comp Physiol 2000, 279:R2057-R2065.
30. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
31. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., Quon M.J. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85:2402-2410.
32. Folch J., Sloane M., Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957, 226:497-509.
33. Frayn K.N., Maycock P.F. Skeletal muscle triacylglycerol in the rat: methods for sampling and measurement, and studies of biological variability. J Lipid Res 1980, 21:139-144.
34. Denton R.M., Randle P.J. Concentrations of glycerides and phospholipids in rat heart and gastrocnemius muscle: effects of alloxan-diabetes and perfusion. Biochem J 1967, 104:416-422.
35. Catalano K.J., Stefanovski D., Bergman R.N. Critical role of the mesenteric depot versus other intra-abdominal adipose depots in the development of insulin resistance in young rats. Diabetes 2010, 59:1416-1423.
36. Rabe K., Lehrke M., Parhofer K.G., Broedl U.C. Adipokines and insulin resistance. Mol Med 2008, 14:741-751.
37. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006, 116:1784-1792.
38. Pravenec M., Kazdová L., Landa V., Zidek V., Mlejnek P., Jansa P., et al. Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat. J Biol Chem 2003, 278:45209-45215.
39. Sell H., Dietze-Schroeder D., Kaiser U., Eckel J. Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle. Endocrinology 2006, 147:2458-2467.
40. Hegarty B.D., Furler S.M., Ye J., Cooney G.J., Kraegen E.W. The role of intramuscular lipid in insulin resistance. Acta Physiol Scand 2003, 178:373-383.
41. DeFronzo R.A., Ferrannini E., Sato Y., Felig P., Wahren J. Synergistic interaction between exercise and insulin on peripheral glucose uptake. J Clin Invest 1981, 68:1468-1474.
42. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002, 8:1288-1295.
43. Lin E., Phillips L.S., Ziegler T.R., Schmotzer B., Wu K., Gu L.H., et al. Increases in adiponectin predict improved liver, but not peripheral, insulin sensitivity in severely obese women during weight loss. Diabetes 2007, 56:735-742.